Fundraising September 15, 2024 – October 1, 2024
About fundraising
books search
books
articles search
articles
Fundraising:
19.6% raised
Log In
Log In
to access more features
personal recommendations
Telegram Bot
download history
send to Email or Kindle
manage booklists
save to favorites
Personal
Book Requests
Explore
Z-Recommend
Booklists
Most Popular
Categories
Contribution
Donate
Uploads
Litera Library
Donate paper books
Add paper books
Search paper books
Open LITERA Point
Terms search
Main
Terms search
search
1
Adult Leukemias 1
Springer Netherlands
Robert C. Gallo
,
Flossie Wong-Staal
,
Francis Ruscetti (auth.)
,
Clara D. Bloomfield (eds.)
leukemia
patients
acute
remission
therapy
marrow
chemotherapy
leukemic
studies
survival
cases
adult
virus
induction
reported
tcgf
clinical
patient
adults
response
lymphoblastic
duration
treated
related
chromosome
viruses
median
rate
factors
relapse
leukemias
methotrexate
leukaemia
prognostic
vitro
infection
lymphoma
cytosine
immunologic
dose
arabinoside
transplantation
growth
gtx
hodgkin
specific
abnormalities
therapeutic
figure
daunorubicin
Year:
1982
Language:
english
File:
PDF, 9.37 MB
Your tags:
0
/
0
english, 1982
2
Acute Nonlymphocytic Leukaemia in Adults: Treatment and infection prevention
De Gruyter Mouton
A. W. Dekker
patients
acute
leukaemia
remission
trimethoprim
leukemia
sulfamethoxazole
infections
infection
induction
therapy
chemotherapy
colistin
resistant
meningeal
nonlymphocytic
cytosine
arabinoside
tract
microorganisms
gram
marrow
prevention
rate
survival
colonization
studies
selective
treated
factors
negative
antibiotics
clinical
incidence
intensive
intern
adult
adults
duration
prophylactic
relapse
bacteria
cent
leukaemic
myelogenous
response
decontamination
patient
alimentary
resistance
Year:
1984
Language:
english
File:
PDF, 4.87 MB
Your tags:
0
/
0
english, 1984
3
New Findings on Aclarubicin in the Treatment of Acute Myeloid Leukemia
Springer-Verlag Berlin Heidelberg
P. S. Mitrou (auth.)
,
Prof. Dr. W. Hiddemann
,
Prof. Dr. R. Mertelsmann (eds.)
patients
acute
leukemia
dose
therapy
aclacinomycin
remission
toxicity
relapse
cytosine
arabinoside
induction
acm
refractory
acla
etoposide
response
median
treated
marrow
patient
relapsed
myeloid
aclarubicin
chemotherapy
daunorubicin
effects
previously
rate
criteria
daily
survival
hiddemann
anll
myelodysplastic
regimen
antileukemic
mds
myelogenous
advanced
observed
pretreated
studies
intermediate
overall
partial
syndromes
effective
frg
obtained
Year:
1990
Language:
english
File:
PDF, 1.57 MB
Your tags:
0
/
0
english, 1990
1
Follow
this link
or find "@BotFather" bot on Telegram
2
Send /newbot command
3
Specify a name for your chatbot
4
Choose a username for the bot
5
Copy an entire last message from BotFather and paste it here
×
×